EUVIMEDEUVIMED entdecken
Multizentrische StudieFall-Kontroll-StudieOpen Access · CC BY 4.0

Genome-wide nucleosome footprints of plasma cfDNA predict preterm birth: A case-control study

Zhiwei Guo iD, Ke Wang, Xiang Huang, Kun Li, Guojun Ouyang, Xu Yang iD, Jiayu Tan, Haihong Shi, Liangping Luo, Min Zhang, Bowei Han iD, Xiangming Zhai und 6 weitere

PLOS Medicine · 15.04.2025 · 22 (4) · e1004571

DOI: 10.1371/journal.pmed.1004571 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS Medicine, online erschienen am 15.04.2025. Verfasst von Zhiwei Guo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Chi…. Hauptthemen laut MEDLINE: Premature Birth, Cell-Free Nucleic Acids, Nucleosomes. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Medical and health key projects of Zhongshan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preterm birth (PTB) occurs in approximately 11% of all births worldwide, resulting in significant morbidity and mortality for both mothers and their offspring. Identifying pregnancies at risk of preterm birth during early pregnancy may help improve interventions and reduce its incidence. Plasma cell-free DNA (cfDNA), derived from placenta and other maternal tissues, serves as a dynamic indicator of biological processes and pathological changes in pregnancy. These properties establish cfDNA as a valuable biomarker for investigating pregnancy complications, including PTB. Methods and findings To date, there are few methods available for PTB prediction that have been developed with large sample sizes, high-throughput screening, and validated in independent cohorts. To address this gap, we established a large-scale, multi-center case-control study involving 2,590 pregnancies (2,072 full-term and 518 preterm) from three independent hospitals to develop a spontaneous preterm birth classifier. We performed whole-genome sequencing on cfDNA, focusing on promoter profiling (read depth of promoter regions spanning from −1 to +1 kb around transcriptional start sites). Using four machine learning models and two feature selection algorithms, we developed classifiers for predicting preterm birth. Among these, the classifier based on the support vector machine model, named PTerm ( P romoter profiling classifier for pre term prediction), exhibited the highest area under the curve (AUC) value of 0.878 (0.852–0.904) following leave-one-out cross-validation. Additionally, PTerm exhibited strong performance in three independent validation cohorts, achieving an overall AUC of 0.849 (0.831–0.866).

Conclusions

In summary, PTerm demonstrated high accuracy in predicting preterm birth. Additionally, it can be utilized with current non-invasive prenatal test data without changing its procedures or increasing detection cost, making it easily adaptable for preclinical tests.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthCell-Free Nucleic AcidsNucleosomesHumansFemalePregnancyCase-Control StudiesAdultBiomarkersWhole Genome SequencingPromoter Regions, GeneticInfant, NewbornSupport Vector Machine

Substanzen

Cell-Free Nucleic AcidsNucleosomesBiomarkers

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), Guangzhou, China.
  • Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
  • Department of Obstetrics and Gynaecology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Prenatal Diagnosis Center, Foshan Women and Children Hospital, Foshan, Guangdong, China.
  • Guangzhou Darui Biotechnology Co, Ltd., Guangzhou, China.

ORCID-Profile: Zhiwei Guo, Xu Yang, Bowei Han, Jinhai Deng, Xuexi Yang, Jia Tang

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Medical and health key projects of Zhongshan
  • Guangzhou Key Laboratory of Molecular and Functional Imaging for Clinical Translation
  • Medical Scientific Research Foundation of Guangdong Province
  • The Research Foundation of Guangdong Provincial Reproductive Science Institute

Zitieren

APA

Guo, Z., Wang, K., Huang, X., Li, K., Ouyang, G., Yang, X., Tan, J., Shi, H., Luo, L., Zhang, M., Han, B., Zhai, X., Deng, J., Beatson, R., Wu, Y., Yang, F., Yang, X., & Tang, J. (2025). Genome-wide nucleosome footprints of plasma cfDNA predict preterm birth: A case-control study. PLOS Medicine, 22(4), e1004571. https://doi.org/10.1371/journal.pmed.1004571

Vancouver

Guo Z, Wang K, Huang X, Li K, Ouyang G, Yang X, et al. Genome-wide nucleosome footprints of plasma cfDNA predict preterm birth: A case-control study. PLOS Medicine. 2025;22(4):e1004571. doi:10.1371/journal.pmed.1004571

BibTeX
@article{Guo2025,
  author = {Guo, Zhiwei and Wang, Ke and Huang, Xiang and Li, Kun and Ouyang, Guojun and Yang, Xu and Tan, Jiayu and Shi, Haihong and Luo, Liangping and Zhang, Min and Han, Bowei and Zhai, Xiangming and Deng, Jinhai and Beatson, Richard and Wu, Yingsong and Yang, Fang and Yang, Xuexi and Tang, Jia},
  title = {Genome-wide nucleosome footprints of plasma cfDNA predict preterm birth: A case-control study},
  journal = {PLOS Medicine},
  year = {2025},
  volume = {22},
  number = {4},
  pages = {e1004571},
  doi = {10.1371/journal.pmed.1004571}
}
Kostenlos starten →